LT3201177T - Mono- arba dipakeistieji indolai kaip dengės viruso replikacijos slopikliai - Google Patents

Mono- arba dipakeistieji indolai kaip dengės viruso replikacijos slopikliai

Info

Publication number
LT3201177T
LT3201177T LTEP15771593.9T LT15771593T LT3201177T LT 3201177 T LT3201177 T LT 3201177T LT 15771593 T LT15771593 T LT 15771593T LT 3201177 T LT3201177 T LT 3201177T
Authority
LT
Lithuania
Prior art keywords
diplomated
indoles
mono
creative
virus replications
Prior art date
Application number
LTEP15771593.9T
Other languages
English (en)
Inventor
Bart Kesteleyn
Jean-Francois Bonfanti
Tim JONCKERS
Pierre Raboisson
Dorothée BARDIOT
Arnaud Marchand
Original Assignee
Janssen Pharmaceuticals, Inc.
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54207512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3201177(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceuticals, Inc., Katholieke Universiteit Leuven filed Critical Janssen Pharmaceuticals, Inc.
Publication of LT3201177T publication Critical patent/LT3201177T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEP15771593.9T 2014-10-01 2015-09-30 Mono- arba dipakeistieji indolai kaip dengės viruso replikacijos slopikliai LT3201177T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14187373 2014-10-01
EP15156073 2015-02-23
PCT/EP2015/072534 WO2016050831A1 (en) 2014-10-01 2015-09-30 Mono- or di-substituted indoles as dengue viral replication inhibitors

Publications (1)

Publication Number Publication Date
LT3201177T true LT3201177T (lt) 2019-03-12

Family

ID=54207512

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP15771593.9T LT3201177T (lt) 2014-10-01 2015-09-30 Mono- arba dipakeistieji indolai kaip dengės viruso replikacijos slopikliai

Country Status (31)

Country Link
US (1) US10206902B2 (lt)
EP (1) EP3201177B1 (lt)
JP (1) JP6701185B2 (lt)
KR (1) KR102478309B1 (lt)
CN (1) CN107001265B (lt)
AU (1) AU2015326920A1 (lt)
BR (1) BR112017006708A2 (lt)
CA (1) CA2958022A1 (lt)
CL (1) CL2017000742A1 (lt)
CY (1) CY1121972T1 (lt)
DK (1) DK3201177T3 (lt)
EA (1) EA033845B1 (lt)
ES (1) ES2711117T3 (lt)
HR (1) HRP20190139T1 (lt)
HU (1) HUE042628T2 (lt)
IL (1) IL251401A0 (lt)
LT (1) LT3201177T (lt)
MA (1) MA40769B1 (lt)
ME (1) ME03344B (lt)
MX (1) MX2017004298A (lt)
PH (1) PH12017500503A1 (lt)
PL (1) PL3201177T3 (lt)
PT (1) PT3201177T (lt)
RS (1) RS58394B1 (lt)
SG (1) SG11201702464WA (lt)
SI (1) SI3201177T1 (lt)
SM (1) SMT201900093T1 (lt)
TW (1) TW201619130A (lt)
UY (1) UY36339A (lt)
WO (1) WO2016050831A1 (lt)
ZA (1) ZA201702299B (lt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
JP6662865B2 (ja) 2014-10-01 2020-03-11 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ボロン酸誘導体
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) * 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
HRP20210847T1 (hr) 2016-03-31 2021-07-23 Janssen Pharmaceuticals, Inc. Supstituirani derivati indola kao inhibitori replikacije denga virusa
MX2018011788A (es) 2016-03-31 2019-05-20 Janssen Pharmaceuticals Inc Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue.
KR102359766B1 (ko) * 2016-04-01 2022-02-07 얀센 파마슈티칼즈, 인코포레이티드 뎅기 바이러스 복제 억제제로서 치환된 인돌 화합물 유도체
JOP20170069B1 (ar) * 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
EA201992782A1 (ru) 2017-05-22 2020-03-24 Янссен Фармасьютикалз, Инк. Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
CN110753682B (zh) 2017-05-22 2023-06-30 杨森制药公司 作为登革热病毒复制抑制剂的经取代的吲哚啉衍生物
CN114989131B (zh) * 2022-05-30 2023-10-24 云南大学 N’-(2-(苯并[1,3]二氧戊烷-5-基)酰基)芳酰肼类化合物及其合成和用途
WO2026057013A1 (zh) * 2024-09-14 2026-03-19 华武生物医药技术(湖北)有限责任公司 一类登革热病毒复制抑制剂、其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928645A1 (fr) * 2008-03-14 2009-09-18 Sanofi Aventis Sa Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
PE20110368A1 (es) * 2008-08-18 2011-06-13 Univ Yale Moduladores de mif
CA2785563C (en) * 2010-01-15 2019-05-14 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
GB201116559D0 (en) * 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
AU2015326930B2 (en) * 2014-10-01 2020-03-26 Janssen Pharmaceuticals, Inc. Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JOP20160086B1 (ar) * 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) * 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك

Also Published As

Publication number Publication date
DK3201177T3 (en) 2019-03-04
HRP20190139T1 (hr) 2019-03-22
UY36339A (es) 2016-04-01
CY1121972T1 (el) 2020-10-14
US10206902B2 (en) 2019-02-19
AU2015326920A1 (en) 2017-03-02
SG11201702464WA (en) 2017-04-27
JP6701185B2 (ja) 2020-05-27
WO2016050831A1 (en) 2016-04-07
CN107001265A (zh) 2017-08-01
ES2711117T3 (es) 2019-04-30
JP2017531638A (ja) 2017-10-26
TW201619130A (zh) 2016-06-01
PH12017500503A1 (en) 2017-08-30
IL251401A0 (en) 2017-05-29
KR20170063675A (ko) 2017-06-08
US20170224658A1 (en) 2017-08-10
ZA201702299B (en) 2018-12-19
PT3201177T (pt) 2019-02-12
CN107001265B (zh) 2021-06-15
CL2017000742A1 (es) 2017-11-03
PL3201177T3 (pl) 2019-05-31
BR112017006708A2 (pt) 2017-12-26
EP3201177A1 (en) 2017-08-09
SMT201900093T1 (it) 2019-02-28
CA2958022A1 (en) 2016-04-07
HUE042628T2 (hu) 2019-07-29
MA40769B1 (fr) 2019-03-29
KR102478309B1 (ko) 2022-12-15
MA40769A (fr) 2017-09-09
MX2017004298A (es) 2017-07-19
EA033845B1 (ru) 2019-12-02
ME03344B (me) 2019-10-20
SI3201177T1 (sl) 2019-05-31
EA201790700A1 (ru) 2017-08-31
EP3201177B1 (en) 2018-11-21
RS58394B1 (sr) 2019-04-30

Similar Documents

Publication Publication Date Title
LT3201177T (lt) Mono- arba dipakeistieji indolai kaip dengės viruso replikacijos slopikliai
EP3866381C0 (en) IMPROVING COMMUNICATION EFFECTIVENESS
AP00819S1 (en) Lantern
GB201405834D0 (en) Oncolytic virus
GB201406608D0 (en) Virus
CL2015000533S1 (es) Motocicleta
DK3018977T3 (da) Lygtenetværk
CL2014003291S1 (es) Motocicleta
EP3145958C0 (en) CELLULOSE MICROFIBRILS
UA32586S (uk) Мотоцикл
CL2015000845S1 (es) Motocicleta
FI20145134L (fi) Huuva
GB201403579D0 (en) Turnable waveguide
GB201419572D0 (en) Virus
CL2015001101S1 (es) Motocicleta
EP3258297C0 (de) Lichtgitteranordnung
DK3154942T3 (da) Fremstilling af piperidin-4-carbothioamid
FR3021937B1 (fr) Servofrein a depression
ES1107755Y (es) Horquilla mejorada
DK3334807T3 (da) Ildtænder
ES1135384Y (es) Escalera multifunción
ES1133533Y (es) Motosierra
FI10458U1 (fi) Hirsiliitos
UA31495S (uk) Пістолет
FI11088U1 (fi) Tuloilmalaite